Selected research
Industry Research
DNA Repair Drugs Industry Research Report 2026
Market perspective
The global DNA Repair Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for DNA Repair Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for DNA Repair Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for DNA Repair Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of DNA Repair Drugs include Johnson & Johnson, Jiangsu Hengrui Medicine, GlaxoSmithKline, Tesaro, National Institutes of Health, National Health Service, KuDOS Pharmaceuticals, Karyopharm Therapeutics and Jonsson Comprehensive Cancer Center, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global DNA Repair Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
DNA Repair Drugs Market by Company
Johnson & Johnson
Jiangsu Hengrui Medicine
GlaxoSmithKline
Tesaro
National Institutes of Health
National Health Service
KuDOS Pharmaceuticals
Karyopharm Therapeutics
Jonsson Comprehensive Cancer Center
German Breast Group
Georgetown University
Genentech
Cambridge University Hospitals NHS Foundation Trust
British Columbia Cancer Agency
Bristol Myers Squibb
ARCAGY/ GINECO GROUP
4SC AG
DNA Repair Drugs Segment by Type
PARP Inhibitors
Other
DNA Repair Drugs Segment by Application
Oncological
Stroke
DNA Repair Drugs Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA Repair Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of DNA Repair Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA Repair Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of DNA Repair Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of DNA Repair Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of DNA Repair Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- PARP Inhibitors
- Other
Applications
- Oncological
- Stroke
Companies covered
- Johnson & Johnson
- Jiangsu Hengrui Medicine
- GlaxoSmithKline
- Tesaro
- National Institutes of Health
- National Health Service
- KuDOS Pharmaceuticals
- Karyopharm Therapeutics
- Jonsson Comprehensive Cancer Center
- German Breast Group
- Georgetown University
- Genentech
- Cambridge University Hospitals NHS Foundation Trust
- British Columbia Cancer Agency
- Bristol Myers Squibb
- ARCAGY/ GINECO GROUP
- 4SC AG
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global DNA Repair Drugs Market Size (2021-2032)
- 2.2.2 Global DNA Repair Drugs Sales (2021-2032)
- 2.2.3 Global DNA Repair Drugs Market Average Price (2021-2032)
- 2.3 DNA Repair Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 PARP Inhibitors
- 2.3.3 Other
- 2.4 DNA Repair Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Oncological
- 2.4.3 Stroke
3 Market Competitive Landscape by Manufacturers
- 3.1 Global DNA Repair Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global DNA Repair Drugs Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global DNA Repair Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global DNA Repair Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global DNA Repair Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of DNA Repair Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of DNA Repair Drugs, Product Type & Application
- 3.8 Global Manufacturers of DNA Repair Drugs, Established Date
- 3.9 Global DNA Repair Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Johnson & Johnson
- 4.1.1 Johnson & Johnson Company Information
- 4.1.2 Johnson & Johnson Business Overview
- 4.1.3 Johnson & Johnson DNA Repair Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Johnson & Johnson DNA Repair Drugs Product Portfolio
- 4.1.5 Johnson & Johnson Recent Developments
- 4.2 Jiangsu Hengrui Medicine
- 4.2.1 Jiangsu Hengrui Medicine Company Information
- 4.2.2 Jiangsu Hengrui Medicine Business Overview
- 4.2.3 Jiangsu Hengrui Medicine DNA Repair Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Jiangsu Hengrui Medicine DNA Repair Drugs Product Portfolio
- 4.2.5 Jiangsu Hengrui Medicine Recent Developments
- 4.3 GlaxoSmithKline
- 4.3.1 GlaxoSmithKline Company Information
- 4.3.2 GlaxoSmithKline Business Overview
- 4.3.3 GlaxoSmithKline DNA Repair Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 GlaxoSmithKline DNA Repair Drugs Product Portfolio
- 4.3.5 GlaxoSmithKline Recent Developments
- 4.4 Tesaro
- 4.4.1 Tesaro Company Information
- 4.4.2 Tesaro Business Overview
- 4.4.3 Tesaro DNA Repair Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Tesaro DNA Repair Drugs Product Portfolio
- 4.4.5 Tesaro Recent Developments
- 4.5 National Institutes of Health
- 4.5.1 National Institutes of Health Company Information
- 4.5.2 National Institutes of Health Business Overview
- 4.5.3 National Institutes of Health DNA Repair Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 National Institutes of Health DNA Repair Drugs Product Portfolio
- 4.5.5 National Institutes of Health Recent Developments
- 4.6 National Health Service
- 4.6.1 National Health Service Company Information
- 4.6.2 National Health Service Business Overview
- 4.6.3 National Health Service DNA Repair Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 National Health Service DNA Repair Drugs Product Portfolio
- 4.6.5 National Health Service Recent Developments
- 4.7 KuDOS Pharmaceuticals
- 4.7.1 KuDOS Pharmaceuticals Company Information
- 4.7.2 KuDOS Pharmaceuticals Business Overview
- 4.7.3 KuDOS Pharmaceuticals DNA Repair Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 KuDOS Pharmaceuticals DNA Repair Drugs Product Portfolio
- 4.7.5 KuDOS Pharmaceuticals Recent Developments
- 4.8 Karyopharm Therapeutics
- 4.8.1 Karyopharm Therapeutics Company Information
- 4.8.2 Karyopharm Therapeutics Business Overview
- 4.8.3 Karyopharm Therapeutics DNA Repair Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Karyopharm Therapeutics DNA Repair Drugs Product Portfolio
- 4.8.5 Karyopharm Therapeutics Recent Developments
- 4.9 Jonsson Comprehensive Cancer Center
- 4.9.1 Jonsson Comprehensive Cancer Center Company Information
- 4.9.2 Jonsson Comprehensive Cancer Center Business Overview
- 4.9.3 Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Jonsson Comprehensive Cancer Center DNA Repair Drugs Product Portfolio
- 4.9.5 Jonsson Comprehensive Cancer Center Recent Developments
- 4.10 German Breast Group
- 4.10.1 German Breast Group Company Information
- 4.10.2 German Breast Group Business Overview
- 4.10.3 German Breast Group DNA Repair Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 German Breast Group DNA Repair Drugs Product Portfolio
- 4.10.5 German Breast Group Recent Developments
- 4.11 Georgetown University
- 4.11.1 Georgetown University Company Information
- 4.11.2 Georgetown University Business Overview
- 4.11.3 Georgetown University DNA Repair Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Georgetown University DNA Repair Drugs Product Portfolio
- 4.11.5 Georgetown University Recent Developments
- 4.12 Genentech
- 4.12.1 Genentech Company Information
- 4.12.2 Genentech Business Overview
- 4.12.3 Genentech DNA Repair Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Genentech DNA Repair Drugs Product Portfolio
- 4.12.5 Genentech Recent Developments
- 4.13 Cambridge University Hospitals NHS Foundation Trust
- 4.13.1 Cambridge University Hospitals NHS Foundation Trust Company Information
- 4.13.2 Cambridge University Hospitals NHS Foundation Trust Business Overview
- 4.13.3 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Product Portfolio
- 4.13.5 Cambridge University Hospitals NHS Foundation Trust Recent Developments
- 4.14 British Columbia Cancer Agency
- 4.14.1 British Columbia Cancer Agency Company Information
- 4.14.2 British Columbia Cancer Agency Business Overview
- 4.14.3 British Columbia Cancer Agency DNA Repair Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 British Columbia Cancer Agency DNA Repair Drugs Product Portfolio
- 4.14.5 British Columbia Cancer Agency Recent Developments
- 4.15 Bristol Myers Squibb
- 4.15.1 Bristol Myers Squibb Company Information
- 4.15.2 Bristol Myers Squibb Business Overview
- 4.15.3 Bristol Myers Squibb DNA Repair Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Bristol Myers Squibb DNA Repair Drugs Product Portfolio
- 4.15.5 Bristol Myers Squibb Recent Developments
- 4.16 ARCAGY/ GINECO GROUP
- 4.16.1 ARCAGY/ GINECO GROUP Company Information
- 4.16.2 ARCAGY/ GINECO GROUP Business Overview
- 4.16.3 ARCAGY/ GINECO GROUP DNA Repair Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 ARCAGY/ GINECO GROUP DNA Repair Drugs Product Portfolio
- 4.16.5 ARCAGY/ GINECO GROUP Recent Developments
- 4.17 4SC AG
- 4.17.1 4SC AG Company Information
- 4.17.2 4SC AG Business Overview
- 4.17.3 4SC AG DNA Repair Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 4SC AG DNA Repair Drugs Product Portfolio
- 4.17.5 4SC AG Recent Developments
5 Global DNA Repair Drugs Market Scenario by Region
- 5.1 Global DNA Repair Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global DNA Repair Drugs Sales by Region: 2021-2032
- 5.2.1 Global DNA Repair Drugs Sales by Region: 2021-2026
- 5.2.2 Global DNA Repair Drugs Sales by Region: 2027-2032
- 5.3 Global DNA Repair Drugs Revenue by Region: 2021-2032
- 5.3.1 Global DNA Repair Drugs Revenue by Region: 2021-2026
- 5.3.2 Global DNA Repair Drugs Revenue by Region: 2027-2032
- 5.4 North America DNA Repair Drugs Market Facts & Figures by Country
- 5.4.1 North America DNA Repair Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America DNA Repair Drugs Sales by Country (2021-2032)
- 5.4.3 North America DNA Repair Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe DNA Repair Drugs Market Facts & Figures by Country
- 5.5.1 Europe DNA Repair Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe DNA Repair Drugs Sales by Country (2021-2032)
- 5.5.3 Europe DNA Repair Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific DNA Repair Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific DNA Repair Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific DNA Repair Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific DNA Repair Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America DNA Repair Drugs Market Facts & Figures by Country
- 5.7.1 South America DNA Repair Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America DNA Repair Drugs Sales by Country (2021-2032)
- 5.7.3 South America DNA Repair Drugs Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa DNA Repair Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa DNA Repair Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa DNA Repair Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa DNA Repair Drugs Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global DNA Repair Drugs Sales by Type (2021-2032)
- 6.1.1 Global DNA Repair Drugs Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global DNA Repair Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global DNA Repair Drugs Revenue by Type (2021-2032)
- 6.2.1 Global DNA Repair Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global DNA Repair Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global DNA Repair Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global DNA Repair Drugs Sales by Application (2021-2032)
- 7.1.1 Global DNA Repair Drugs Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global DNA Repair Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global DNA Repair Drugs Revenue by Application (2021-2032)
- 7.2.1 Global DNA Repair Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global DNA Repair Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global DNA Repair Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 DNA Repair Drugs Value Chain Analysis
- 8.1.1 DNA Repair Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 DNA Repair Drugs Production Mode & Process
- 8.2 DNA Repair Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 DNA Repair Drugs Distributors
- 8.2.3 DNA Repair Drugs Customers
9 Global DNA Repair Drugs Analyzing Market Dynamics
- 9.1 DNA Repair Drugs Industry Trends
- 9.2 DNA Repair Drugs Industry Drivers
- 9.3 DNA Repair Drugs Industry Opportunities and Challenges
- 9.4 DNA Repair Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst